CA1340807C
(en)
*
|
1988-02-24 |
1999-11-02 |
Lawrence T. Malek |
Nucleic acid amplification process
|
DK0457824T4
(da)
*
|
1989-02-13 |
2004-10-11 |
Geneco Pty Ltd |
Detektion af en nukleinsyresekvens eller en ændring deri
|
US5856092A
(en)
*
|
1989-02-13 |
1999-01-05 |
Geneco Pty Ltd |
Detection of a nucleic acid sequence or a change therein
|
IE66597B1
(en)
*
|
1989-05-10 |
1996-01-24 |
Akzo Nv |
Method for the synthesis of ribonucleic acid (RNA)
|
DE3929030A1
(de)
*
|
1989-09-01 |
1991-03-07 |
Boehringer Mannheim Gmbh |
Verfahren zur vermehrung von nukleinsaeuren
|
US5545522A
(en)
*
|
1989-09-22 |
1996-08-13 |
Van Gelder; Russell N. |
Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
|
US7049102B1
(en)
*
|
1989-09-22 |
2006-05-23 |
Board Of Trustees Of Leland Stanford University |
Multi-gene expression profile
|
US5629153A
(en)
*
|
1990-01-10 |
1997-05-13 |
Chiron Corporation |
Use of DNA-dependent RNA polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
|
WO1991010746A1
(en)
|
1990-01-10 |
1991-07-25 |
Chiron Corporation |
Dna-dependent rna polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
|
US7585512B1
(en)
|
1990-05-08 |
2009-09-08 |
Thomas Jefferson University |
Composition and method of using tumor cells
|
US5518900A
(en)
*
|
1993-01-15 |
1996-05-21 |
Molecular Tool, Inc. |
Method for generating single-stranded DNA molecules
|
WO1992020820A1
(en)
*
|
1991-05-15 |
1992-11-26 |
Vanderbilt University |
Method to determine metastatic potential of tumor cells
|
US5169766A
(en)
*
|
1991-06-14 |
1992-12-08 |
Life Technologies, Inc. |
Amplification of nucleic acid molecules
|
WO1993005184A1
(en)
*
|
1991-09-10 |
1993-03-18 |
Love Jack D |
Dna/rna target and signal amplification
|
DE4213029A1
(de)
*
|
1991-09-26 |
1993-04-01 |
Boehringer Mannheim Gmbh |
Verfahren zur spezifischen vervielfaeltigung von nukleins aeuresequenzen
|
US5981179A
(en)
*
|
1991-11-14 |
1999-11-09 |
Digene Diagnostics, Inc. |
Continuous amplification reaction
|
US5256555A
(en)
|
1991-12-20 |
1993-10-26 |
Ambion, Inc. |
Compositions and methods for increasing the yields of in vitro RNA transcription and other polynucleotide synthetic reactions
|
CA2135073C
(en)
*
|
1992-05-06 |
2002-11-19 |
Daniel L. Kacian |
Nucleic acid sequence amplification method, composition and kit
|
US5834202A
(en)
*
|
1992-08-04 |
1998-11-10 |
Replicon, Inc. |
Methods for the isothermal amplification of nucleic acid molecules
|
WO1994003624A1
(en)
*
|
1992-08-04 |
1994-02-17 |
Auerbach Jeffrey I |
Methods for the isothermal amplification of nucleic acid molecules
|
US5614389A
(en)
*
|
1992-08-04 |
1997-03-25 |
Replicon, Inc. |
Methods for the isothermal amplification of nucleic acid molecules
|
US6261808B1
(en)
|
1992-08-04 |
2001-07-17 |
Replicon, Inc. |
Amplification of nucleic acid molecules via circular replicons
|
US5733733A
(en)
*
|
1992-08-04 |
1998-03-31 |
Replicon, Inc. |
Methods for the isothermal amplification of nucleic acid molecules
|
DE4238699A1
(de)
*
|
1992-11-17 |
1994-05-19 |
Boehringer Mannheim Gmbh |
Einfaches Nukleinsäurevermehrungsverfahren
|
US5605798A
(en)
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
US5863724A
(en)
*
|
1994-04-13 |
1999-01-26 |
Baylor College Of Medicine |
Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy
|
US5942391A
(en)
*
|
1994-06-22 |
1999-08-24 |
Mount Sinai School Of Medicine |
Nucleic acid amplification method: ramification-extension amplification method (RAM)
|
US6593086B2
(en)
|
1996-05-20 |
2003-07-15 |
Mount Sinai School Of Medicine Of New York University |
Nucleic acid amplification methods
|
FR2724934B1
(fr)
*
|
1994-09-26 |
1997-01-24 |
Bio Merieux |
Oligonucleotide chimere et son utilisation dans l'obtention de transcrits d'un acide nucleique
|
US5789169A
(en)
*
|
1994-11-03 |
1998-08-04 |
Regents Of The University Of California |
Methods for the diagnosis of glaucoma
|
US5849879A
(en)
*
|
1994-11-03 |
1998-12-15 |
The Regents Of The University Of California |
Methods for the diagnosis of glaucoma
|
US5606043A
(en)
|
1994-11-03 |
1997-02-25 |
The Regents Of The University Of California |
Methods for the diagnosis of glaucoma
|
US5654141A
(en)
*
|
1994-11-18 |
1997-08-05 |
Thomas Jefferson University |
Amplification based detection of bacterial infection
|
JP3453745B2
(ja)
*
|
1995-02-02 |
2003-10-06 |
横河電機株式会社 |
光ファイバ検査装置
|
US5844235A
(en)
*
|
1995-02-02 |
1998-12-01 |
Yokogawa Electric Corporation |
Optical frequency domain reflectometer for use as an optical fiber testing device
|
JP3453746B2
(ja)
*
|
1995-02-09 |
2003-10-06 |
横河電機株式会社 |
光ファイバ検査装置
|
US5753787A
(en)
*
|
1995-04-10 |
1998-05-19 |
Yale University |
Nucleic acids encoding ancylostoma secreted protein
|
US6852487B1
(en)
|
1996-02-09 |
2005-02-08 |
Cornell Research Foundation, Inc. |
Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
|
EP1736554B1
(de)
|
1996-05-29 |
2013-10-09 |
Cornell Research Foundation, Inc. |
Bestimmung von Unterschieden in der Nukleinsäuresequenz mittels einer Kombination von Ligasebestimmung und Polymerasekettenreaktion
|
US6132954A
(en)
*
|
1996-08-20 |
2000-10-17 |
Baylor College Of Medicine |
Methods of screening for agents that delay a cell cycle and compositions comprising era and an analogue of wild-type era
|
US6043283A
(en)
*
|
1996-09-20 |
2000-03-28 |
Baylor College Of Medicine |
Tyramine compounds and their neuronal effects
|
US6071493A
(en)
*
|
1996-09-20 |
2000-06-06 |
Baylor College Of Medicine |
Method of screening for an agent that inhibits mononuclear phagocyte-plaque component complex formation
|
CA2270132A1
(en)
*
|
1996-11-06 |
1998-05-14 |
Sequenom, Inc. |
Dna diagnostics based on mass spectrometry
|
US6025133A
(en)
*
|
1996-12-30 |
2000-02-15 |
Gen-Probe Incorporated |
Promoter-sequestered oligonucleoside and method of use
|
US7138511B1
(en)
|
1997-01-28 |
2006-11-21 |
The Regents Of The University Of California |
Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US6475724B1
(en)
|
1997-01-28 |
2002-11-05 |
The Regents Of The University Of California |
Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US6171788B1
(en)
|
1997-01-28 |
2001-01-09 |
The Regents Of The University Of California |
Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US6482795B1
(en)
|
1997-01-30 |
2002-11-19 |
Myriad Genetics, Inc. |
Tumor suppressor designated TS10q23.3
|
US6262242B1
(en)
|
1997-01-30 |
2001-07-17 |
Board Of Regents, The University Of Texas System |
Tumor suppressor designated TS10Q23.3
|
US6713300B1
(en)
|
1997-02-27 |
2004-03-30 |
University Of Utah Research Foundation |
Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter
|
US6117643A
(en)
|
1997-11-25 |
2000-09-12 |
Ut Battelle, Llc |
Bioluminescent bioreporter integrated circuit
|
DE69835538T2
(de)
|
1997-12-18 |
2008-01-03 |
Monsanto Technology Llc |
Insekten-resistante transgene pflanzen und verfahren zur verbesserung von der aktivität von delta-endotoxine gegen insekte
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US7029861B1
(en)
|
1998-09-15 |
2006-04-18 |
Board Of Regents, The University Of Texas System |
LPS-response gene compositions and methods
|
US6656471B1
(en)
|
1998-11-17 |
2003-12-02 |
Board Of Regents, The University Of Texas System |
HIV-specific T-cell induction
|
US6156515A
(en)
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
US7037682B2
(en)
|
1999-03-13 |
2006-05-02 |
Government Of The Republic Of Singapore |
In vitro activity assay for human hepatitis B virus (HBV) DNA polymerase, and its use for screening for inhibitors of HBV DNA polymerase
|
WO2000066780A2
(en)
|
1999-04-30 |
2000-11-09 |
University Of Florida |
Adeno-associated virus-delivered ribozyme compositions and methods of use
|
PT1471926E
(pt)
|
1999-06-01 |
2011-03-11 |
Baylor College Medicine |
Composições e métodos para a utilização terapêutica de uma sequência associada a atonal
|
AU5882000A
(en)
|
1999-06-22 |
2001-01-09 |
Invitrogen Corporation |
Improved primers and methods for the detection and discrimination of nucleic acids
|
US6830902B1
(en)
|
1999-07-02 |
2004-12-14 |
Invitrogen Corporation |
Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
ES2303525T3
(es)
|
2000-04-21 |
2008-08-16 |
Corixa Corporation |
Compuestos y metodos para el tratamiento y diagnostico de infeccion por chlamydia.
|
JP2004513615A
(ja)
|
2000-06-28 |
2004-05-13 |
コリクサ コーポレイション |
肺癌の治療および診断のための組成物および方法
|
AU7333701A
(en)
|
2000-07-10 |
2002-01-21 |
Univ Texas |
Chromosome 3p21.3 genes are tumor suppressors
|
US6858413B2
(en)
|
2000-12-13 |
2005-02-22 |
Nugen Technologies, Inc. |
Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
|
JP3853161B2
(ja)
*
|
2001-02-19 |
2006-12-06 |
独立行政法人科学技術振興機構 |
微量mRNA及びcDNAの増幅方法
|
BR0205268A
(pt)
|
2001-03-09 |
2004-11-30 |
Nugen Technologies Inc |
Processos e composições para a mplificação de sequências de rna
|
WO2002089747A2
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US8137911B2
(en)
|
2001-05-22 |
2012-03-20 |
Cellscript, Inc. |
Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
|
CA2448097A1
(en)
|
2001-05-22 |
2002-11-28 |
University Of Chicago |
N4 virion single-stranded dna dependent rna polymerase
|
AU2003303395A1
(en)
|
2001-05-22 |
2004-07-22 |
Dahl, Gary, A. |
Target-dependent transcription using deletion mutants of n4 rna polymerase
|
EP1430140B1
(de)
|
2001-08-01 |
2010-09-15 |
University of Utah |
Am n-terminus trunkierte isoformen von zyklischen phosphodiesterasen pde3a
|
EP1908851A3
(de)
|
2001-09-19 |
2008-06-25 |
Intergenetics Incorporated |
Genetische Analyse zur Stratifizierung eines Krebsrisikos
|
WO2003025141A2
(en)
|
2001-09-19 |
2003-03-27 |
Intergenetics Incorporated |
Genetic analysis for stratification of cancer risk
|
US20030165859A1
(en)
|
2001-10-23 |
2003-09-04 |
Invitrogen Corporation |
Primers and methods for the detection and discrimination of nucleic acids
|
PT1458888E
(pt)
|
2001-12-10 |
2011-06-01 |
Novartis Ag |
Métodos para tratar a psicose e a esquizofrenia baseados em polimorfismos no gene do cntf
|
CA2476755C
(en)
|
2001-12-17 |
2014-08-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
AU2003304195B8
(en)
|
2002-07-15 |
2008-08-28 |
Board Of Regents, The University Of Texas System |
Combinatorial protein library screening by periplasmic expression
|
CN1754002B
(zh)
|
2002-08-12 |
2010-09-08 |
杰能斯有限公司 |
涉及痘病毒和癌的组合物及制备方法
|
AU2002951411A0
(en)
|
2002-09-16 |
2002-09-26 |
The University Of Sydney |
Genotype screen
|
AU2003294447A1
(en)
|
2002-11-21 |
2004-06-18 |
Epicentre Technologies |
Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
RU2389732C2
(ru)
|
2003-01-06 |
2010-05-20 |
Корикса Корпорейшн |
Некоторые аминоалкилглюкозаминидфосфатные производные и их применение
|
ES2338654T5
(es)
|
2003-01-29 |
2017-12-11 |
454 Life Sciences Corporation |
Amplificación de ácidos nucleicos en emulsión de perlas
|
DK2374900T3
(en)
|
2003-03-07 |
2016-10-17 |
Rubicon Genomics Inc |
Polynucleotides for amplification and analysis of the total genomic and total transcription libraries generated by a DNA polymerization
|
EP2390352A1
(de)
|
2003-03-18 |
2011-11-30 |
Quantum Genetics Ireland Limited |
Systeme und Methoden zur Erhöhung der Milchproduktion bei Tieren
|
CA2521084A1
(en)
|
2003-04-14 |
2004-10-28 |
Nugen Technologies, Inc. |
Global amplification using a randomly primed composite primer
|
US20050059024A1
(en)
|
2003-07-25 |
2005-03-17 |
Ambion, Inc. |
Methods and compositions for isolating small RNA molecules
|
CN1878866B
(zh)
|
2003-07-25 |
2012-08-01 |
安比恩股份有限公司 |
用于从固定的样品中制备rna的方法和组合物
|
ATE489481T1
(de)
|
2003-09-12 |
2010-12-15 |
Univ Cincinnati |
Verfahren zur risikobeurteilung, überlebensvorhersage und behandlung von herzversagen und anderen leiden auf der grundlage von polymorphismen adrenerger rezeptoren
|
WO2005112544A2
(en)
|
2004-02-19 |
2005-12-01 |
The Governors Of The University Of Alberta |
Leptin promoter polymorphisms and uses thereof
|
WO2005118810A1
(en)
|
2004-06-03 |
2005-12-15 |
Athlomics Pty Ltd |
Agents and methods for diagnosing stress
|
WO2006031955A2
(en)
|
2004-09-14 |
2006-03-23 |
The Regents Of The University Of Colorado, A Body Corporate |
Method for treatment with bucindolol based on genetic targeting
|
EP1874955A4
(de)
|
2005-02-28 |
2009-05-06 |
Bioquest Inc |
Verfahren zur durchführung direkter enzymatischer reaktionen unter beteiligung von nukleinsäuremolekülen
|
WO2006095941A1
(en)
|
2005-03-05 |
2006-09-14 |
Seegene, Inc. |
Processes using dual specificity oligonucleotide and dual specificity oligonucleotide
|
KR100977186B1
(ko)
|
2005-03-05 |
2010-08-23 |
주식회사 씨젠 |
이중 특이성 올리고뉴클레오타이드를 사용한 방법 및 이중특이성 올리고뉴클레오타이드
|
EP2476761A3
(de)
|
2005-07-07 |
2012-10-17 |
Athlomics Pty Ltd |
Polynukleotidmarkergene und ihre Expression zur Diagnose von Endotoxämie
|
US7494788B2
(en)
|
2005-07-11 |
2009-02-24 |
Molecular Kinetics, Inc. |
Entropic bristle domain sequences and their use in recombinant protein production
|
US7838646B2
(en)
|
2005-08-18 |
2010-11-23 |
Quest Diagnostics Investments Incorporated |
Cystic fibrosis transmembrane conductance regulator gene mutations
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
WO2007030759A2
(en)
|
2005-09-07 |
2007-03-15 |
Nugen Technologies, Inc. |
Improved nucleic acid amplification procedure
|
ATE518007T1
(de)
|
2005-10-21 |
2011-08-15 |
Genenews Inc |
Verfahren und vorrichtung zur korrelierung der ebenen von biomarker-produkten mit erkrankungen
|
EP1940755A2
(de)
|
2005-10-28 |
2008-07-09 |
Praecis Pharmaceuticals Inc. |
Verfahren zur identifikation von verbindungen von interesse mithilfe kodierter bibliotheken
|
EP1952147A2
(de)
|
2005-11-16 |
2008-08-06 |
Novartis AG |
Biomarker zur anti-nogo-a-antikörperbehandlung bei rückenmarksverletzung
|
US8014957B2
(en)
|
2005-12-15 |
2011-09-06 |
Fred Hutchinson Cancer Research Center |
Genes associated with progression and response in chronic myeloid leukemia and uses thereof
|
WO2007106579A2
(en)
|
2006-03-15 |
2007-09-20 |
Micronics, Inc. |
Integrated nucleic acid assays
|
BR122015030334B8
(pt)
|
2006-05-25 |
2018-05-22 |
Monsanto Technology Llc |
processo para seleção de uma planta de soja resistente à ferrugem asiática da soja
|
US8481023B2
(en)
|
2006-09-15 |
2013-07-09 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
KR100823642B1
(ko)
*
|
2006-09-26 |
2008-04-21 |
고려대학교 산학협력단 |
큐티나아제 생산 균주, 그 선별 방법, 상기 균주에 의해생산된 큐티나아제 및 상기 큐티나아제를 포함하는 조성물
|
ATE555128T1
(de)
|
2006-11-30 |
2012-05-15 |
Res Dev Foundation |
Verbesserte immunglobulin-bibliotheken
|
EP2121956B1
(de)
|
2006-12-21 |
2016-08-17 |
Gen-Probe Incorporated |
Verfahren und zusammensetzungen zur amplizierung von nukleinsäuren
|
US7794937B2
(en)
|
2006-12-22 |
2010-09-14 |
Quest Diagnostics Investments Incorporated |
Cystic fibrosis transmembrane conductance regulator gene mutations
|
EP3492596A1
(de)
|
2007-04-09 |
2019-06-05 |
University of Florida Research Foundation, Inc. |
Raav-vektorzusammensetzungen mit tyrosinmodifizierten kapsidproteinen und verfahren zu deren verwendung
|
DK2155789T3
(da)
|
2007-05-01 |
2013-10-21 |
Res Dev Foundation |
Immunoglobulin-Fc-biblioteker
|
EP2173872B1
(de)
|
2007-06-29 |
2014-04-02 |
CellScript, Inc. |
Copy-dna und sense-rna
|
WO2010022787A1
(en)
*
|
2008-08-29 |
2010-03-04 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Fibre monitoring in optical networks
|
CN102458446B
(zh)
|
2009-04-22 |
2017-06-13 |
印第安那大学科技研究公司 |
用于治疗慢性阻塞性肺病和哮喘的组合物和方法
|
JP5785942B2
(ja)
|
2009-06-29 |
2015-09-30 |
ルミネックス コーポレーション |
ヘアピンコンフォメーションを有するキメラプライマーおよびその使用法
|
US9169512B2
(en)
|
2009-07-01 |
2015-10-27 |
Gen-Probe Incorporated |
Methods and compositions for nucleic acid amplification
|
ES2652340T3
(es)
|
2009-07-17 |
2018-02-01 |
Bioatla Llc |
Selección y evolución simultáneas e integradas de rendimiento y expresión de proteínas humanas en huéspedes de producción
|
US9409983B2
(en)
|
2009-07-23 |
2016-08-09 |
The Board Of Trustess Of The University Of Illinois |
Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
|
WO2011032088A1
(en)
|
2009-09-11 |
2011-03-17 |
Arca Biopharma, Inc. |
Polymorphisms in the pde3a gene
|
EP3409119B1
(de)
|
2009-09-14 |
2020-08-12 |
SillaJen Biotherapeutics, Inc. |
Krebskombinationstherapie mit onkolytischem vaccinia virus
|
KR20110050327A
(ko)
|
2009-11-07 |
2011-05-13 |
주식회사 씨젠 |
Thd 프라이머 타겟 검출
|
BR112012013664B1
(pt)
|
2009-12-10 |
2020-11-10 |
Turnstone Limited Partnership |
rabdovírus oncolítico
|
CN102762744B
(zh)
|
2009-12-21 |
2017-07-25 |
Seegene株式会社 |
利用靶信号产生引物进行的靶检测
|
CA2822747A1
(en)
|
2009-12-23 |
2011-06-30 |
Arca Biopharma, Inc. |
Use of s-(6-nitro-oxi-hexahydro-furo[3,2-b]thioacetate in the treatment of cardiovascular disorders associated with oxide synthase dysfunction
|
KR101851117B1
(ko)
|
2010-01-29 |
2018-04-23 |
마이크로닉스 인코포레이티드. |
샘플-투-앤서 마이크로유체 카트리지
|
US11225655B2
(en)
|
2010-04-16 |
2022-01-18 |
Nuevolution A/S |
Bi-functional complexes and methods for making and using such complexes
|
ES2711256T3
(es)
|
2010-04-23 |
2019-04-30 |
Univ Florida |
Composiciones de rAAV-guanilato ciclasa y métodos para tratar la amaurosis congénita de Leber 1 (LCA1)
|
KR101176139B1
(ko)
|
2010-05-20 |
2012-08-22 |
광주과학기술원 |
관절염 동물모델로서 연골 특이적 HIF?2α 형질전환 마우스 및 이의 용도
|
KR101223660B1
(ko)
|
2010-05-20 |
2013-01-17 |
광주과학기술원 |
HIF-2α 억제제를 유효성분으로 포함하는 관절염 예방 또는 치료용 약제학적 조성물
|
CA2804746C
(en)
|
2010-07-16 |
2022-01-11 |
Jay M. Short |
Novel methods of protein evolution
|
CA2803011C
(en)
|
2010-07-16 |
2019-12-03 |
Tocagen Inc. |
Retrovirus detection
|
EP3578205A1
(de)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
|
US20120237975A1
(en)
|
2010-10-01 |
2012-09-20 |
Jason Schrum |
Engineered nucleic acids and methods of use thereof
|
WO2012090073A2
(en)
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
CN103429258B
(zh)
|
2011-01-04 |
2016-03-09 |
新罗杰公司 |
通过施用溶瘤痘苗病毒生成针对肿瘤抗原的抗体和生成肿瘤特异性补体依赖性细胞毒性
|
AU2012214643B2
(en)
|
2011-02-07 |
2016-12-15 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides
|
CA2828532A1
(en)
|
2011-02-28 |
2012-11-22 |
University Of Iowa Research Foundation |
Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
|
WO2012120377A2
(en)
|
2011-03-08 |
2012-09-13 |
King Abdullah University Of Science And Technology |
Molecular biomarker set for early detection of ovarian cancer
|
EP2691101A2
(de)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
EP2694678A2
(de)
|
2011-04-04 |
2014-02-12 |
Netherland Cancer Institute |
Verfahren und zusammensetzungen zur vorhersage der resistenz gegenüber einer antikrebsbehandlung
|
KR101291668B1
(ko)
|
2011-04-21 |
2013-08-01 |
서울대학교산학협력단 |
미코박테리아―대장균용 셔틀 벡터 및 이의 용도
|
EP2701736A1
(de)
|
2011-04-25 |
2014-03-05 |
Advanced Bioscience Laboratories, Inc. |
Trunkierte hiv-hüllproteine (env), verfahren und zugehörige zusammensetzungen
|
US9364532B2
(en)
|
2011-06-08 |
2016-06-14 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
WO2012177595A1
(en)
|
2011-06-21 |
2012-12-27 |
Oncofactor Corporation |
Compositions and methods for the therapy and diagnosis of cancer
|
US10040853B2
(en)
|
2011-09-09 |
2018-08-07 |
Fred Hutchinson Cancer Research Center |
Methods and compositions involving NKG2D inhibitors and cancer
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
WO2013045505A1
(en)
|
2011-09-28 |
2013-04-04 |
Novartis Ag |
Biomarkers for raas combination therapy
|
CA2850624A1
(en)
|
2011-10-03 |
2013-04-11 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
JP6285865B2
(ja)
|
2011-11-14 |
2018-02-28 |
アルファシグマ ソシエタ ペル アチオニ |
うつ病を有する対象のための処置レジメンを選択するためのアッセイ及び方法
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
WO2013093629A2
(en)
|
2011-12-20 |
2013-06-27 |
Netherlands Cancer Institute |
Modular vaccines, methods and compositions related thereto
|
CA2861387A1
(en)
|
2012-02-02 |
2013-08-08 |
Invenra, Inc. |
High throughput screen for biologically active polypeptides
|
JP6224067B2
(ja)
|
2012-03-29 |
2017-11-01 |
ノバルティス アーゲー |
診断用薬
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
CA2868398A1
(en)
|
2012-04-02 |
2013-10-10 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
化学修飾mRNA
|
EP2740805B1
(de)
|
2012-12-07 |
2019-02-20 |
SuppreMol GmbH |
Stratifizierung und Behandlung von Patienten, die an idiopathischer thrombozytopenischer Purpura leiden
|
EP2935908B1
(de)
|
2012-12-21 |
2019-08-14 |
PerkinElmer Health Sciences, Inc. |
Fluidkreisläufe und zugehörige herstellungsverfahren
|
WO2014100743A2
(en)
|
2012-12-21 |
2014-06-26 |
Micronics, Inc. |
Low elasticity films for microfluidic use
|
WO2014100725A1
(en)
|
2012-12-21 |
2014-06-26 |
Micronics, Inc. |
Portable fluorescence detection system and microassay cartridge
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
WO2014127478A1
(en)
|
2013-02-21 |
2014-08-28 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Vaccine composition
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
KR101403507B1
(ko)
|
2013-03-21 |
2014-06-09 |
주식회사 현일바이오 |
결핵균 및 비결핵 마이코박테리아의 선택적 검출 방법, 그리고 이를 이용한 키트
|
KR101507505B1
(ko)
|
2013-04-18 |
2015-04-07 |
사회복지법인 삼성생명공익재단 |
제 1 형 근긴장성 이영양증의 진단 방법
|
WO2014182847A1
(en)
|
2013-05-07 |
2014-11-13 |
Micronics, Inc. |
Device for preparation and analysis of nucleic acids
|
CA2911303C
(en)
|
2013-05-07 |
2021-02-16 |
Micronics, Inc. |
Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
|
WO2014182844A1
(en)
|
2013-05-07 |
2014-11-13 |
Micronics, Inc. |
Microfluidic devices and methods for performing serum separation and blood cross-matching
|
US20160186263A1
(en)
|
2013-05-09 |
2016-06-30 |
Trustees Of Boston University |
Using plexin-a4 as a biomarker and therapeutic target for alzheimer's disease
|
EP3052106A4
(de)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynukleotide zur codierung immunmodulierender polypeptide
|
US20150098940A1
(en)
|
2013-10-03 |
2015-04-09 |
Oklahoma Medical Research Foundation |
Biomarkers for Systemic Lupus Erythematosus Disease Activity, and Intensity and Flare
|
JP2016538829A
(ja)
|
2013-10-03 |
2016-12-15 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
低密度リポタンパク質受容体をコードするポリヌクレオチド
|
CA2935577C
(en)
|
2014-01-07 |
2023-04-04 |
Bioatla, Llc |
Proteins targeting orthologs
|
US20170113221A1
(en)
|
2014-06-11 |
2017-04-27 |
Micronics, Inc. |
Microfluidic cartridges and apparatus with integrated assay controls for analysis of nucleic acids
|
WO2016086227A2
(en)
|
2014-11-26 |
2016-06-02 |
The Regents Of The University Of California |
Therapeutic compositions comprising transcription factors and methods of making and using the same
|
CA2970143A1
(en)
|
2014-12-08 |
2016-06-16 |
Berg Llc |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
KR101718800B1
(ko)
|
2015-01-21 |
2017-03-24 |
주식회사 디알나노 |
약물 및 siRNA의 공동―운반용 나노복합체 및 이의 용도
|
US10457737B2
(en)
|
2015-02-09 |
2019-10-29 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
|
CN108026575B
(zh)
|
2015-07-17 |
2022-08-19 |
哈佛学院董事及会员团体 |
扩增核酸序列的方法
|
US9789087B2
(en)
|
2015-08-03 |
2017-10-17 |
Thomas Jefferson University |
PAR4 inhibitor therapy for patients with PAR4 polymorphism
|
WO2017040380A2
(en)
|
2015-08-28 |
2017-03-09 |
Research Development Foundation |
Engineered antibody fc variants
|
KR101651817B1
(ko)
|
2015-10-28 |
2016-08-29 |
대한민국 |
Ngs 라이브러리 제작용 프라이머 세트 및 이를 이용한 ngs 라이브러리 제작방법 및 키트
|
KR101845957B1
(ko)
|
2016-02-23 |
2018-04-05 |
전남대학교기술지주회사(주) |
프로히비틴 유전자 타깃 백혈병 진단용 키트 및 이를 이용한 진단 방법
|
JP7042755B2
(ja)
|
2016-06-05 |
2022-03-28 |
バーグ エルエルシー |
患者層別化及び潜在的バイオマーカー同定のためのシステム及び方法
|
KR102402712B1
(ko)
|
2016-12-29 |
2022-05-26 |
주식회사 씨젠 |
프라이머 다이머 형성을 감소시키고 증폭 효율을 증가시키는 방법
|
KR101936799B1
(ko)
|
2017-01-09 |
2019-01-11 |
주식회사 엠이티라이프사이언스 |
구강전암의 치료용 약학 조성물 및 구강전암 또는 구강암의 예측 또는 진단 방법
|
CN110462062A
(zh)
|
2017-01-26 |
2019-11-15 |
俄克拉荷马医学研究基金会 |
系统性红斑狼疮疾病活动性、强度和急性发作的生物标志物
|
KR101956315B1
(ko)
|
2017-07-19 |
2019-03-08 |
국민대학교 산학협력단 |
파킨슨병 바이오마커로서의 miR494 및 이를 이용한 진단키트
|
WO2019017680A2
(ko)
|
2017-07-19 |
2019-01-24 |
국민대학교 산학협력단 |
파킨슨병 바이오마커로서의 miRNA 및 이를 이용한 진단키트
|
CN116585308A
(zh)
|
2018-05-25 |
2023-08-15 |
Arca生物制药有限公司 |
涉及布新洛尔治疗心房颤动的方法和组合物
|
JP2022509018A
(ja)
|
2018-10-31 |
2022-01-20 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ |
放射線誘発肺障害のためのバイオマーカー及び使用方法
|
SG11202111824UA
(en)
|
2019-04-30 |
2021-11-29 |
Larimar Therapeutics Inc |
Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
|
WO2020251306A1
(en)
|
2019-06-14 |
2020-12-17 |
Seegene, Inc. |
Computer-implemented method for collaborative development of reagents for detection of target nucleic acids
|
KR20230007464A
(ko)
|
2020-06-05 |
2023-01-12 |
주식회사 씨젠 |
호흡기 병원체 검출을 위한 검체수송 키트 및 이를 이용한 호흡기 병원체 검출방법
|
CN115989415A
(zh)
|
2020-06-30 |
2023-04-18 |
健肺生命人工智能公司 |
用于检测肺癌的方法
|
WO2022047359A1
(en)
|
2020-08-31 |
2022-03-03 |
Berg Llc |
Protein biomarkers for pancreatic cancer
|
IL307528A
(en)
|
2021-04-06 |
2023-12-01 |
Bpgbio Inc |
Protein markers for the prognosis of breast cancer progression
|
IL307531A
(en)
|
2021-04-06 |
2023-12-01 |
Bpgbio Inc |
Protein markers for estrogen receptor (ER)-like and estrogen receptor (ER)-negative breast cancer
|
CA3214819A1
(en)
|
2021-04-06 |
2022-10-13 |
Guisong WANG |
Protein markers for estrogen receptor (er)-positive luminal a(la)-like and luminal b1 (lb1)-like breast cancer
|
KR20240035874A
(ko)
|
2021-07-21 |
2024-03-18 |
주식회사 씨젠 |
검수 수집 장치 및 검체 수집 방법
|
CA3232702A1
(en)
*
|
2021-09-23 |
2023-03-30 |
Geert Meersseman |
Nucleic acid detection
|
US20230357851A1
(en)
|
2022-04-06 |
2023-11-09 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring frataxin-replacement therapy
|
WO2023230531A1
(en)
|
2022-05-24 |
2023-11-30 |
Lunglife Ai, Inc. |
Methods for detecting circulating genetically abnormal cells
|
WO2023240201A1
(en)
|
2022-06-08 |
2023-12-14 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring progression and treatment of leigh syndrome
|
WO2023239940A1
(en)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|